I-Corps alumni company Astria Biosciences has been awarded a $275,000 Small Business Innovation Research (SBIR) Phase I grant from the National Science Foundation. The startup, which spun out of research conducted at the University of Pittsburgh, is developing the first simple, whole blood-based test to detect the presence and monitor the progression of cerebral aneurysms.
Learn more about Astria Biosciences’ recent accomplishments and hear from the startup’s founders, Kamil Nowicki and Adi Mittal, on the University of Pittsburgh Innovation Institute’s blog.